Patents by Inventor Maribel Espinoza

Maribel Espinoza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11857557
    Abstract: The present invention relates to an oral dissolvable film (ODF) containing an active ingredient (e.g., vitamin D) that is, outside of the ODF, relatively unstable to at least one of heat, light, moisture, and oxygen. The present invention also relates to methods of manufacturing and using the same.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: January 2, 2024
    Inventors: Maribel Espinoza, Jose Bernardo
  • Publication number: 20220047504
    Abstract: An oral dissolvable film, methods of making the oral dissolvable film, and methods of using the oral dissolvable film. The oral dissolvable film contains pores located therein.
    Type: Application
    Filed: May 27, 2021
    Publication date: February 17, 2022
    Applicant: Cure Pharmaceutical Holding Corp.
    Inventors: Robert Davidson, Steven Ruhl, Vered Gigi, Bhaumik Patel, Jose Bernardo, Maribel Espinoza
  • Publication number: 20220023198
    Abstract: The present invention relates to an oral soluble film (OSF), methods of orally administering the same, and methods of manufacturing the same. The oral soluble film includes sildenafil citrate, and can further include a binder, filler, flavoring agent, plasticizer, sweetening agent, preservative, solvent, and optionally coloring agent. The active ingredient and excipients can be provided and present in an amount effective to achieve desired physical and performance characteristics of the OSF.
    Type: Application
    Filed: September 29, 2021
    Publication date: January 27, 2022
    Applicant: CURE Pharmaceutical Holding Corp.
    Inventors: Maribel Espinoza, Vered Gigi
  • Patent number: 11179331
    Abstract: The present invention relates to an oral soluble film (OSF), methods of orally administering the same, and methods of manufacturing the same. The oral soluble film includes sildenafil citrate, and can further include a binder, filler, flavoring agent, plasticizer, sweetening agent, preservative, solvent, and optionally coloring agent. The active ingredient and excipients can be provided and present in an amount effective to achieve desired physical and performance characteristics of the OSF.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: November 23, 2021
    Assignee: CURE PHARMACEUTCAI HOLDING CORP
    Inventors: Maribel Espinoza, Vered Gigi
  • Publication number: 20210322306
    Abstract: The present invention relates to an oral dissolvable film (ODF), methods of orally administering the same, and methods of manufacturing the same. The ODF includes a high load of binder. Such an ODF, containing a high load of binder, can achieve the requisite physical and performance characteristics and can be manufactured on a commercial scale, while demonstrating that the ODF is safe and effective to consumers for its intended use. This also includes formulating and configuring the ODF to deliver the API as desired, via, e.g., enteral, transmucosal, sublingual, and/or buccal, when the administration is oral.
    Type: Application
    Filed: April 21, 2021
    Publication date: October 21, 2021
    Applicant: CURE Pharmaceutical Holding Corp.
    Inventors: Maribel Espinoza, Vered Gigi, Armen Pirjanian
  • Publication number: 20210145849
    Abstract: The present invention relates to an oral dissolvable film (ODF) containing an active ingredient (e.g., vitamin D) that is, outside of the ODF, relatively unstable to at least one of heat, light, moisture, and oxygen. The present invention also relates to methods of manufacturing and using the same.
    Type: Application
    Filed: September 30, 2020
    Publication date: May 20, 2021
    Applicant: CURE PHARMACEUTICAL HOLDING CORP.
    Inventors: Maribel Espinoza, Jose Bernardo